2026-01-14 - Analysis Report
**Company Overview**
Intuitive Surgical Inc is a medical devices company specializing in robotic-assisted surgical systems and instruments.

**Return Rate Comparison**

* **Rate**: Cumulative return of review stock: **78.50%**
* **Rate_vs**: Cumulative return of comparison stock (S&P 500, VOO): **93.94%**
* **Divergence**: Difference in cumulative return on the last day of the data: **-7.80%

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 49.0% | 29.0% | 45.0% | 1.2 | 57.2B |
| 2017-2019  | 40.0% | 29.0% | 23.0% | 1.4 | 70.6B |
| 2018-2020  | -8.0% | 29.0% | -29.0% | 1.2 | 97.8B |
| 2019-2021  | 26.0% | 21.1% | -17.0% | 1.2 | 128.8B |
| 2020-2022  | -18.0% | 48.9% | -16.0% | 1.2 | 95.1B |
| 2021-2023  | -12.0% | 48.9% | -13.0% | 1.4 | 120.9B |
| 2022-2024  | 35.0% | 38.0% | 16.0% | 1.3 | 187.1B |
| 2023-2025  | 60.0% | 28.0% | -2.0% | 1.2 | 203.0B |

## Simple Analysis
The company's 5-year cumulative return rate is 78.50%. The 5-year cumulative return rate of the S&P 500 (VOO) is 93.94%. The current rate of divergence is -7.80, indicating a relatively close but lower performance rate of ISRG compared to the S&P 500.

## Recent Stock Price Fluctuations

* **5-day SMA**: $579.63
* **20-day SMA**: $572.56
* **60-day SMA**: $556.73
* **Current Close**: $561.82

## Simple Analysis
The stock price fluctuations show that the 5-day SMA and the 20-day SMA are higher than the current close, indicating a short-term price rebound.

## RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence

* **MRI (Market Risk Indicator)**: 0.70
* **RSI**: 39.20
* **PPO**: -0.25
* **Expected Return (%)**: 3.80%

## Simple Analysis
The MRI of 0.70 falls into the medium investment category. The RSI at 39.20 is close to a neutral position. The PPO of -0.25 shows a potential short position. The expected return is 3.80%, indicating an expected return above the S&P 500.

## Recent News & Significant Events

* [2026-01-08] Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
* [2026-01-12] Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know - Nasdaq
* [2025-12-24] This Medical Robotics Name Wins FDA Greenlight; Its Stock Nears A Buy Point - Investor's Business Daily
* [2026-01-10] How Intuitive Surgical Stock Gained 40% - Trefis
* [2026-01-07] Is ISRG Stock Still A Buy At $600? - Forbes
* [2026-01-12] Is It Too Late To Consider Intuitive Surgical (ISRG) After Strong Multi Year Share Gains? - simplywall.st

## Simple Analysis
Recent news and events indicate that the company faced challenges in the market but has seen positive trends in the past, such as a 40% gain in stock value.

## Analyst Opinions
 
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.06 (~Buy)
- Opinions: 29
- Target Price (avg/high/low): 608.26 / 740.00 / 378.00

## Simple Analysis
The overall analyst consensus is a 'Buy' recommendation with a mean score of 2.06, indicating a neutral to positive view of the company. The target price range is between 378.00 and 740.00.

## Recent Earnings Analysis

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-22 | 1.98 | $2.51 B$ |
| 2025-07-23 | 1.84 | $2.44 B$ |
| 2025-04-23 | 1.95 | $2.25 B$ |
| 2024-10-18 | 1.59 | $2.04 B$ |
| 2025-10-22 | 1.59 | $2.04 B$ |

## Simple Analysis
The recent quarterly EPS and revenue show an increasing trend, with the highest EPS of 1.98 achieved in the latest quarter. The highest revenue of $2.51B was also achieved in the latest quarter

## Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $2.51B | 66.36% |
| 2025-06-30 | $2.44B | 66.31% |
| 2025-03-31 | $2.25B | 64.69% |
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |

## Simple Analysis
The quarterly revenue has increased from $2.04B to $2.51B, a growth of 23.08%. The profit margins have fluctuated but generally remain above 64%.

## Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $16.93B | 4.16% |
| 2025-06-30 | $17.85B | 3.69% |
| 2025-03-31 | $17.11B | 4.08% |
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |

## Simple Analysis
The equity has increased from $15.58B to $16.93B, a growth of 8.54%. The ROE has also fluctuated but generally remained between 3.6% and 4.2%.

## Comprehensive Analysis

Overall, the company's recent stock price fluctuations, earnings analysis, and financial performance indicate a positive trend, but the market risk indicator suggests a need for caution. The analyst consensus recommends 'Buy' with a target price between 378.00 and 740.00. However, the expected return may be affected by the market conditions and the company's specific challenges.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.